2 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
Follow Sinusitis: new trials by email Literature Review of Sinusitis trials Research Report on Sinusitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray Dupilumab - Allergic Fungal Rhinosinusitis (AFRS), Chronic Rhinosinusitis (CRS) | Phase 3 | Withdrawn | National Institute on Deafness and Other Communication Disorders (NIDCD) | 2024-07-17 | 2024-07-25 | |
| Pulmozyme in Cystic Fibrosis With Sinusitis Pulmozyme single use ampule, placebo - Sinusitis, Cystic Fibrosis | Phase 3 | Withdrawn | Milton S. Hershey Medical Center | 2013-07-01 | 2017-07-21 |
Allergic Fungal Sinusitis (1) · Asthma (1) · Cystic Fibrosis (1) · Nasal Polyps (1)
Infections (2) · Lung Diseases (2) · Nose Diseases (2) · Otorhinolaryngologic Diseases (2) · Paranasal Sinus Diseases (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Bacterial Infections and Mycoses (1) · Bronchial Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Genetic Diseases, Inborn (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1)
dornase alfa (1) · dupilumab (1)
Milton S. Hershey Medical Center (1) · National Institute on Deafness and Other Communication Disorders (NIDCD) (1)
United States (1)
Joshua Levy, M.D. (1) · Timothy Craig, DO (1)